Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

Clinical trial NCT02007629 · COMPLETED

Trial details

NCT number: NCT02007629
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2014-02-18
Primary completion: 2016-12-29
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.